SCHEDULE 13D/A//SEC Filing
X4 Pharmaceuticals, Inc SCHEDULE 13D/A
Accession 0001072613-25-000747
CIK 0001917895other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 6:04 PM ET
Size
92.2 KB
Accession
0001072613-25-000747
Issuer
Growth Equity Opportunities 18 VGE, LLC
CIK 0001917895
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001917895
Filing Metadata
- Form type
- SCHEDULE 13D/A
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 6:04 PM ET
- Size
- 92.2 KB